Titre : Racépinéfrine

Racépinéfrine : Questions médicales fréquentes

Termes MeSH sélectionnés :

Network Meta-Analysis
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Racépinéfrine : Questions médicales les plus fréquentes", "headline": "Racépinéfrine : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Racépinéfrine : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-21", "dateModified": "2025-03-18", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Racépinéfrine" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Épinéphrine", "url": "https://questionsmedicales.fr/mesh/D004837", "about": { "@type": "MedicalCondition", "name": "Épinéphrine", "code": { "@type": "MedicalCode", "code": "D004837", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.657.166.175.461" } } }, "about": { "@type": "MedicalCondition", "name": "Racépinéfrine", "alternateName": "Racepinephrine", "code": { "@type": "MedicalCode", "code": "D064705", "codingSystem": "MeSH" } }, "citation": [ { "@type": "ScholarlyArticle", "name": "Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension.", "datePublished": "2022-11-03", "url": "https://questionsmedicales.fr/article/36326841", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00392-022-02120-0" } }, { "@type": "ScholarlyArticle", "name": "Effectiveness of different treatments for odontogenic keratocyst: a network meta-analysis.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36150944", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.ijom.2022.09.004" } }, { "@type": "ScholarlyArticle", "name": "Herbal Medicines for Rhinosinusitis: A Systematic Review and Network Meta-analysis.", "datePublished": "2023-01-07", "url": "https://questionsmedicales.fr/article/36609950", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11882-022-01060-z" } }, { "@type": "ScholarlyArticle", "name": "Pregabalin administration in patients with fibromyalgia: a Bayesian network meta-analysis.", "datePublished": "2022-07-15", "url": "https://questionsmedicales.fr/article/35840702", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-022-16146-x" } }, { "@type": "ScholarlyArticle", "name": "Theory and practice of Bayesian and frequentist frameworks for network meta-analysis.", "datePublished": "2022-06-27", "url": "https://questionsmedicales.fr/article/35760451", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjebm-2022-111928" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénols", "item": "https://questionsmedicales.fr/mesh/D010636" }, { "@type": "ListItem", "position": 8, "name": "Catéchols", "item": "https://questionsmedicales.fr/mesh/D002396" }, { "@type": "ListItem", "position": 9, "name": "Catécholamines", "item": "https://questionsmedicales.fr/mesh/D002395" }, { "@type": "ListItem", "position": 10, "name": "Épinéphrine", "item": "https://questionsmedicales.fr/mesh/D004837" }, { "@type": "ListItem", "position": 11, "name": "Racépinéfrine", "item": "https://questionsmedicales.fr/mesh/D064705" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Racépinéfrine - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Racépinéfrine", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-15", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Racépinéfrine", "description": "Comment diagnostiquer une crise d'asthme ?\nQuels tests sont utilisés pour évaluer l'efficacité de la racépinéfrine ?\nQuels symptômes indiquent une obstruction bronchique ?\nComment différencier l'asthme de la BPCO ?\nQuels signes cliniques nécessitent une intervention immédiate ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Racépinéfrine", "description": "Quels sont les effets secondaires courants de la racépinéfrine ?\nComment reconnaître une réaction allergique à la racépinéfrine ?\nQuels symptômes indiquent une surdose de racépinéfrine ?\nQuels symptômes peuvent nécessiter un changement de traitement ?\nQuels signes indiquent une amélioration après traitement ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Racépinéfrine", "description": "Comment prévenir les crises d'asthme ?\nQuels conseils donner aux patients asthmatiques ?\nComment gérer les allergies pour prévenir l'asthme ?\nQuel rôle joue l'exercice dans la prévention de l'asthme ?\nComment la vaccination peut-elle aider les asthmatiques ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Racépinéfrine", "description": "Comment la racépinéfrine est-elle administrée ?\nQuelle est la posologie recommandée pour les adultes ?\nQuels autres traitements peuvent être combinés avec la racépinéfrine ?\nQuand faut-il éviter d'utiliser la racépinéfrine ?\nComment évaluer l'efficacité du traitement par racépinéfrine ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Racépinéfrine", "description": "Quelles sont les complications possibles de l'asthme non contrôlé ?\nComment la racépinéfrine peut-elle affecter le cœur ?\nQuels risques sont associés à une surutilisation de la racépinéfrine ?\nQuelles sont les conséquences d'une mauvaise utilisation des inhalateurs ?\nQuels sont les risques d'une dépendance aux bronchodilatateurs ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Racépinéfrine", "description": "Quels facteurs augmentent le risque d'asthme ?\nComment le tabagisme influence-t-il l'asthme ?\nQuel rôle joue l'obésité dans l'asthme ?\nQuels environnements sont à risque pour les asthmatiques ?\nComment le stress affecte-t-il l'asthme ?", "url": "https://questionsmedicales.fr/mesh/D064705?mesh_terms=Network+Meta-Analysis&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une crise d'asthme ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur les antécédents médicaux, l'examen physique et des tests de fonction pulmonaire." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer l'efficacité de la racépinéfrine ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests de spirométrie mesurent le volume d'air inhalé et expiré pour évaluer la fonction pulmonaire." } }, { "@type": "Question", "name": "Quels symptômes indiquent une obstruction bronchique ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent la toux, la respiration sifflante, et l'essoufflement." } }, { "@type": "Question", "name": "Comment différencier l'asthme de la BPCO ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'asthme est réversible avec des bronchodilatateurs, tandis que la BPCO est généralement irréversible." } }, { "@type": "Question", "name": "Quels signes cliniques nécessitent une intervention immédiate ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Une détresse respiratoire sévère, cyanose ou incapacité à parler sont des signes d'urgence." } }, { "@type": "Question", "name": "Quels sont les effets secondaires courants de la racépinéfrine ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires incluent tremblements, palpitations et nervosité." } }, { "@type": "Question", "name": "Comment reconnaître une réaction allergique à la racépinéfrine ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Les signes incluent éruption cutanée, démangeaisons, et gonflement du visage ou de la gorge." } }, { "@type": "Question", "name": "Quels symptômes indiquent une surdose de racépinéfrine ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent tachycardie, hypertension et agitation excessive." } }, { "@type": "Question", "name": "Quels symptômes peuvent nécessiter un changement de traitement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une aggravation des symptômes respiratoires malgré le traitement peut nécessiter une réévaluation." } }, { "@type": "Question", "name": "Quels signes indiquent une amélioration après traitement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Une diminution de la toux, une respiration plus facile et une meilleure capacité d'exercice sont des signes d'amélioration." } }, { "@type": "Question", "name": "Comment prévenir les crises d'asthme ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les déclencheurs connus, suivre un plan de traitement et utiliser des médicaments préventifs." } }, { "@type": "Question", "name": "Quels conseils donner aux patients asthmatiques ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Éduquer sur l'utilisation correcte des inhalateurs et l'importance de la surveillance des symptômes." } }, { "@type": "Question", "name": "Comment gérer les allergies pour prévenir l'asthme ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les allergènes, utiliser des antihistaminiques et maintenir un environnement propre." } }, { "@type": "Question", "name": "Quel rôle joue l'exercice dans la prévention de l'asthme ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "L'exercice régulier peut améliorer la fonction pulmonaire, mais doit être adapté aux capacités individuelles." } }, { "@type": "Question", "name": "Comment la vaccination peut-elle aider les asthmatiques ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations contre la grippe et le pneumocoque peuvent réduire le risque d'infections respiratoires." } }, { "@type": "Question", "name": "Comment la racépinéfrine est-elle administrée ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Elle est généralement administrée par inhalation via un nébuliseur ou un inhalateur." } }, { "@type": "Question", "name": "Quelle est la posologie recommandée pour les adultes ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "La posologie varie, mais elle est souvent de 0,5 à 1,0 mg par inhalation, selon les besoins." } }, { "@type": "Question", "name": "Quels autres traitements peuvent être combinés avec la racépinéfrine ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des corticostéroïdes inhalés peuvent être utilisés en complément pour un meilleur contrôle de l'asthme." } }, { "@type": "Question", "name": "Quand faut-il éviter d'utiliser la racépinéfrine ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Elle doit être évitée en cas d'hypersensibilité connue ou de maladies cardiaques sévères." } }, { "@type": "Question", "name": "Comment évaluer l'efficacité du traitement par racépinéfrine ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "L'efficacité peut être évaluée par l'amélioration des symptômes et des tests de fonction pulmonaire." } }, { "@type": "Question", "name": "Quelles sont les complications possibles de l'asthme non contrôlé ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des crises d'asthme sévères, des infections pulmonaires et des hospitalisations." } }, { "@type": "Question", "name": "Comment la racépinéfrine peut-elle affecter le cœur ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut provoquer des palpitations et une augmentation de la fréquence cardiaque chez certains patients." } }, { "@type": "Question", "name": "Quels risques sont associés à une surutilisation de la racépinéfrine ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Une surutilisation peut entraîner une tachyphylaxie, réduisant son efficacité et augmentant les effets secondaires." } }, { "@type": "Question", "name": "Quelles sont les conséquences d'une mauvaise utilisation des inhalateurs ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Une mauvaise utilisation peut entraîner un contrôle insuffisant des symptômes et des exacerbations fréquentes." } }, { "@type": "Question", "name": "Quels sont les risques d'une dépendance aux bronchodilatateurs ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Une dépendance peut conduire à une mauvaise gestion de l'asthme et à des crises plus fréquentes." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque d'asthme ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents familiaux, l'exposition à des allergènes et la pollution de l'air sont des facteurs de risque." } }, { "@type": "Question", "name": "Comment le tabagisme influence-t-il l'asthme ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Le tabagisme aggrave les symptômes de l'asthme et augmente le risque de complications." } }, { "@type": "Question", "name": "Quel rôle joue l'obésité dans l'asthme ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "L'obésité peut aggraver l'asthme en augmentant l'inflammation et en réduisant la fonction pulmonaire." } }, { "@type": "Question", "name": "Quels environnements sont à risque pour les asthmatiques ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les environnements avec des allergènes élevés, comme les moisissures et les pollens, sont à risque." } }, { "@type": "Question", "name": "Comment le stress affecte-t-il l'asthme ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Le stress peut déclencher des crises d'asthme en augmentant l'inflammation et la réactivité bronchique." } } ] } ] }

Sources (10000 au total)

Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension.

Sacubitril/valsartan has been demonstrated to reduce blood pressure in hypertensive patients, but the best dose remains unclear. We performed this network meta-analysis to determine the comparative ef... We searched four databases for relevant studies published before January 2022. Mean systolic and diastolic blood pressures in the sitting position (msSBP and msDBP) and ambulatory condition (24-h maSB... In hypertensive patients, 200 mg once daily of sacubitril/valsartan may exert a greater reduction in ambulatory blood pressure than 100 mg once daily and 200 mg once daily may not be inferior to 400 m...

Herbal Medicines for Rhinosinusitis: A Systematic Review and Network Meta-analysis.

To analyze and compare the effects of herbal medicines (HMs) for treating different forms of rhinosinusitis.... Forty-seven randomized controlled trials evaluating 18 HMs in six different rhinosinusitis populations were included in the network meta-analysis. Certainty of evidence was assessed using the Grading ... PROSPERO ID: CRD42022328265 May 10, 2022....

Efficacy of Systemic Treatment in Prostate Cancer Patients With Visceral Metastasis: A Systematic Review, Meta-analysis, and Network Meta-analysis.

There are limited pooled data showing the impact of visceral metastasis on oncologic outcomes in metastatic prostate cancer patients treated with combination systemic therapies. We aimed to analyze an... Three databases were queried in July 2022 for randomized, controlled trials analyzing metastatic prostate cancer patients treated with combination systemic therapy (androgen receptor signaling inhibit... Overall, 12 and 8 randomized, controlled trials were included for systematic review and meta-analyses/network meta-analyses, respectively. In metastatic hormone-sensitive prostate cancer patients, add... Despite aggressive clinical behavior and worse trajectory of metastatic hormone-sensitive prostate cancer and metastatic castration-resistant prostate cancer with visceral metastasis, the effectivenes...

crossnma: An R package to synthesize cross-design evidence and cross-format data using network meta-analysis and network meta-regression.

Although aggregate data (AD) from randomised clinical trials (RCTs) are used in the majority of network meta-analyses (NMAs), other study designs (e.g., cohort studies and other non-randomised studies... We developed the R package crossnma to perform cross-format (IPD and AD) and cross-design (RCT and NRS) NMA and network meta-regression (NMR). The models are implemented as Bayesian three-level hierar... The R package crossnma enables the user to perform NMA and NMR with different data types in a Bayesian framework and facilitates the inclusion of all types of evidence recognising differences in risk ...

The impact of timing on outcomes in appendicectomy: a systematic review and network meta-analysis.

Appendicectomy remains the standard treatment for appendicitis. There is a lack of clarity on the timeframe in which surgery should be performed to avoid unfavourable outcomes.... To perform a systematic review and network meta-analysis to evaluate the impact the (1)time-of-day surgery is performed (2), time elapsed from symptom onset to hospital presentation (patient time) (3)... A systematic review was performed as per PRISMA-NMA guidelines. The time-of-day which surgery was done was divided into day, evening and night. The other groups were divided into < 24 h, 24-48 h and >... Sixteen studies were included with a total of 232,678 patients. The time of day at which surgery was performed had no impact on outcomes. The incidence of complicated appendicitis, post-operative comp... Appendicectomy within 24 h of hospital admission is associated with improved outcomes compared to patients having surgery 24-48 and > 48 h after admission. The time-of-day which surgery is performed d...

Anti-hypertensive therapy for preeclampsia: a network meta-analysis and systematic review.

Preeclampsia (PE) is a pregnancy disorder that represents a major cause of maternal and perinatal morbidity and mortality.... This network meta-analysis was registered with PROSPERO. We searched the PubMed, ClinicalTrials.gov. and Embase databases for studies published from inception to the 31... We included eight randomized controlled trials (RCTs) involving a total of 1192 women with PE; two studies were of high quality and six were of moderate quality. Eight interventions were addressed in ... According to the eight RCTs included in this study, Diltiazem was the most effective in reducing blood pressure in PE patients; Labetalol and Nicardipine also had good effects. Diltiazem is preferred ...

Effective luting agents for glass-fiber posts: A network meta-analysis.

The aims of this study were to systematically review the literature and compare the relative effects of various luting agents on bonding between glass-fiber posts and root canal dentin in short- and l... The literature was electronically searched in PubMed, Embase, and Scopus. A manual search was performed by scanning the reference lists of the included studies.... Two reviewers independently conducted the selection of studies, data extraction, and risk of bias assessment. Pairwise meta-analyses were based on random effect models. Network meta-analyses were cond... One hundred and eighteen studies were included and assessed the effects of five luting agents. For pairwise meta-analyses, in short-term aging conditions, a significantly higher bond strength of self-... The SARC tended to be the most effective luting agent in bonding between glass-fiber posts and root canal dentin in short- and long-term aging conditions....